hematología y oncología
Complicaciones de la transfusión
Referencias generales
1.FDA: Fatalities reported to FDA following blood collection and transfusion: Annual Summary for Fiscal Year 2018. Silver Spring, MD, US Food and Drug Administration, 2018. 2.Holcomb JB, Tilley BC, Baraniuk S, et al: Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.JAMA313(5):471–482, 2015. doi:10.1001/jama.2015.12 